Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ropivacaine 20 mg versus 30 mg for cesarean section spinal anesthesia
IRCT20210114050036N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ropivacaine in None (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Onset of sensory block, Duration of sensory block and 3 more. Started Sep 2018; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on IRCT20210114050036N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210114050036N1.